Think Bioscience closed an oversubscribed $55M Series A round.
- Amount
- $55M
- Stage
- Series A
- Announced
- 20 January 2026
- Leads
- Regeneron Ventures, Innovation Endeavors, Janus Henderson Investors
- Other investors
- T.A. Springer, CE-Ventures, MBX Capital, YK Bioventures, AV8 Ventures, CU Innovations, Buff Gold Ventures
- Use of funds
- Funding will advance the company's internal pipeline of first-in-class programs
- Checked
- Amount and date checked against the press source